Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
250 studies found for:    Open Studies | "Crohn Disease"
Show Display Options
Rank Status Study
21 Recruiting Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease
Condition: Crohn's Disease
Intervention: Drug: Curcumin
22 Recruiting One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Rifaximin DR;   Drug: Placebo
23 Recruiting Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease
Condition: Crohn Disease
Interventions: Procedure: Kono anastomosis;   Procedure: Stapled side-to-side anastomosis
24 Recruiting One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Rifaximin DR;   Drug: Placebo
25 Not yet recruiting Diet for Induction and Maintenance of Remission and Re-biosis in Crohn's Disease
Condition: Crohn's Disease
Interventions: Other: Modified Exclusive Enteral Nutrition;   Other: Crohn's Disease Exclusion Diet;   Other: Partial Enteral Nutrition;   Other: Standard Exclusive Enteral Nutrition
26 Recruiting Evaluation of Efficacy and Safety of MEDI2070 in Subjects With Active, Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: MEDI2070 High dose;   Drug: MEDI2070 High-Med dose;   Drug: MEDI2070 Low-Med dose;   Drug: MEDI2070 Low dose;   Drug: Placebo
27 Recruiting Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: GED-0301
28 Recruiting Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: RHB-104;   Drug: Placebo
29 Recruiting A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GED-0301;   Other: Placebo
30 Not yet recruiting Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Vedolizumab
31 Recruiting Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease
Condition: Crohn's Disease
Interventions: Other: Unique Diet+Partial Enteral Nutrition;   Other: Exclusive Enteral Nutrition (Modulen)
32 Recruiting Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's Disease
Condition: Crohn's Disease
Intervention: Device: vagus nerve stimulation (VNS)
33 Recruiting Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo
34 Not yet recruiting A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo
35 Recruiting A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy
Condition: Crohn's Disease
Interventions: Drug: INFLIXIMAB;   Drug: AZATHIOPRINE;   Drug: MERCAPTOPURINE;   Drug: Methotrexate
36 Recruiting Fecal Transplant for Crohn's Disease
Condition: Crohn Disease
Interventions: Biological: Fecal Microbiota Transplant (FMT);   Biological: Placebo
37 Recruiting Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)
Condition: Crohn's Disease
Intervention: Biological: Stem cells
38 Recruiting Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
39 Recruiting Crohn Disease Exclusion Diet After Single Medication De-escalation
Condition: Crohn Disease
Interventions: Other: Crohn Disease Exclusion Diet;   Other: Free Diet
40 Recruiting A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
Condition: Crohn's Disease
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.